Biology and surgical management of breast cancer

Breast Cancer

Volumn 8, Issue 1, 2001, Pages 16-22

  Noguchi, Masakuni ^a   Taniya, Takao ^b  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^b Futaba Breast Clinic   (Japan)

Author keywords

Breast cancer; Surgical treatment; Tumor biology

Indexed keywords

BREAST TUMOR; CANCER STAGING; FEMALE; HUMAN; LYMPH NODE; LYMPHADENECTOMY; METABOLISM; METHODOLOGY; PATHOLOGY; REVIEW;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; NEOPLASM STAGING;

EID: 0035227991     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/bf02967474     Document Type: Review

References (48)

1. Fisher B: The revolution in breast cancer surgery; Science or anecdotalism? World J Surg 9:655-666, 1985. (Pubitemid 15241688)
2. Hellman S, Harris JR: Natural history of breast cancer. In: Diseases of the Breast, 2 nd ed. JR Harris ed, Lippincott Williams & Wilkins, Philadephia, pp407- 423, 2000.
3. Noguchi M: Is the value of regional lymph node dissection different in breast cancer and gastrointestinal cancer? Breast Cancer 6:171-174, 1992.
4. Veronesi U, Costa A: The role of surgery in the management of primary breast cancer, In: Clinics in Oncology 1(3), M. Baum ed, W.B. Saunders, London, pp853-873, 1982. (Pubitemid 13202860)
5. Hellman S, Harris J: The appropriate breast carcinoma paradigm. Cancer Res 2:339-342, 1987.
6. Cady B, Stone MD, Schuler JG, et al: The new era in breast cancer. Invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 131:301-308, 1996. (Pubitemid 26078817)
7. Tabar L, Gunnar F, Hsiu-Gsi C, et al: Efficacy of breast cancer screening by age. Cancer 75:2507-2517, 1995.
8. Kerikowske K, Grady D, Rubin SM, et al: Efficacy of screening mammography. JAMA 273:149-154, 1995.
9. DeKoning HJ, Boer R, Warmerdam PG, et al: Quantitative interpretation of age-specific mortality reduction from the Swedish breast cancer-screening trials. J Natl Cancer Inst 87:1217-1223, 1995.
10. Shapiro S, Venet W, Strax P, et al: Ten to fourteen years effects of breast cancer screening on mortality. JNCI 69:349-353, 1982.
11. Verbeek ALM, Hendriks JHCL, Holland R, et al: Reduction in breast cancer mortality thru mass screening with modern mammography: First results of the Nijmegen project 1975-1981. Lancet 1:1222- 1224, 1984. (Pubitemid 14105863)
12. Tabar L, Gad A, Holmberg LH, et al: Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1:829-832, 1985. (Pubitemid 15115114)
13. Fisher B: The surgical dilemma in the primary therapy of invasive breast cancer: A critical appraisal. In: Current Problems in Surgery. Year Book Medical Pub., Inc., Chicago, pp4-53, 1970.
14. Haybittle J: The evidence for cure in female breast cancer. Comment Res Breast Dis 3:181, 1983.
15. Brinkley D, Haybittle J: Long-term survival of women with breast cancer. Lancet 1:1118, 1984.
16. Hibberd A, Harwood L, Well J: Long-term prognosis of women with breast cancer in New Zealand: study of survival to 30 years. BMJ 286:1777, 1983.
17. Rutqvist L, Wallgren A: Long-term survival of 458 young breast cancer patients. Cancer 55:658, 1985.
18. Rosen P, Groshen S, Siago P, et al: A long-term followup study of survival in stage I (T1NOM0) and stage II (T1N1M0) breast carcinoma.J Clin Oncol 7:355, 1989.
19. Fisher B, Fisher ER: Studies concerning the regional lymph nodes in cancer. I. Initiation of Immunity. Cancer 27:1001-1004, 1971.
20. Fisher B, Fisher ER: Experimental evidence in support of the dormant tumor cell. Science 130:918-919, 1959.
21. Borgstein P, Meijer S: Historical perspective of lymphatic tumour spread and the emergence of the sentinel node concept. EurJ Surg Oncol24:85-95, 1998.
22. Haigb PI, Brennan MB, Giuliano AE: Surgery for diagnosis and treatment: sentinel lymph node biopsy in breast cancer. Cancer Control 6:301-306, 1999. (Pubitemid 29237346)
23. Zeidman I, Buss JM: Experimental studies on the spread of cancer in the lymphatic system -I. Effectiveness of the lymph node as a barrier to the passage of embolic tumor cells. Cancer Res 14:403-405, 1954.
24. Gilchrist RK: Fundamental factors governing lymphatic spread of carcinoma. Ann Surg 111:630-639, 1940.
25. Tachibana T, Yoshida K: Role of the regional lymph node in cancer metastasis. Cancer Metastasis Rev 5:55-66, 1986.
26. Fisher B, Fisher ER: Barrier functions of lymph node to tumor cells and erythrocytes. Cancer 20:1907-1913, 1967.
27. Fisher B, Fisher ER: The inter-relationship of hematogenous and lymphatic tumor cell dissemination. Surg Gynecol Obstet 122:791-798, 1966.
28. Weiss L: The pathophysiology of metastasis within the lymphatic systems. In: Weiss L, Gilbert HA, Bal- Ion SC eds, Lymphatic System Metastases, GK Hall, Boston, pp2-40, 1980.
29. Pressman JJ, Simon MB, Hank K, et al: Passage of fluids, cells, and bacteria via direct communications between lymph nodes and veins. Surg Gynecol Obstet 115:207-214, 1962.
30. Edwards JM, Kinmonth JB: Lymphovenous shunts in men. BrJMed 4:579-581, 1969.
31. Cady B: Lymph node metastases. Indicators, but not governors of survival. Arch Surg 119:1067-1072, 1984. (Pubitemid 14037331)
32. Liotta LA, Stetler-Stevenson WG: Principles of molecular cell biology of cancer: Cancer metastases. In: DeVita VT Jr, Hellman S, Rosenberg SA eds, Cancer; Principles and Practice of Oncology, JB Lippincott, Philadelphia, pp98-115, 1989.
33. Fisher B, Fisher ER: Studies concerning the regional lymph node in cancer. II. Maintenance of immunity. Cancer 29:1496, 1972.
34. Fisher B, Saffer E, Fisher ER: Studies concerning the regional lymph nodes in cancer. IV. Tumor inhibition by regional lymph node cells. Cancer 33:631, 1974.
35. Fisher B, Montague E, Redmond C, et al: Comparison of radical mastectomy with alternative treatments for primary breast cancer: A first report of results from a prospective randomized clinical trial. Cancer 39:2827-2839, 1980. (Pubitemid 8130398)
36. Fisher B, Redmond C, Fisher ER, et al: Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312:674-681, 1985. (Pubitemid 15134703)
37. Veronesi U, Valagussa P: Inefficacy of internal mammary node dissection in breast cancer surgery. Cancer 47:170-175, 1981. (Pubitemid 11167377)
38. Veronesi U, Marubini E, Mariani L, et al: The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomized trial. Eur J Cancer 35:1320-1325, 1999. (Pubitemid 29397430)
39. Yoshimoto K: Personal communication, 1997.
40. Fisher B: Breast cancer management: alternative to radical mastectomy. N Engl J Med 301:326-328, 1979. (Pubitemid 9244498)
41. McNeil C: Four large studies aim to resolve sentinel node debate. JNCI90:729, 1998.
42. Giuliano AE: Mapping a pathway for axillary staging. A personal perspective on the current status of sentinel lymph node dissection for breast cancer. Arch Surg 134:195-199, 1999.
43. Cote RJ, Rosen PP, Old LJ, et al: Detection of bone marrow micrometastases in patients with early-stage breast cancer. Diagn Oncol 1:37-42, 1991.
44. Menard S, Squicciarini P, Luini A, et al: Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumor prognostic features. Br J Cancer 69:1126-1129, 1994. (Pubitemid 24161873)
45. Harbeck N, Untch M, Pache L, et al: Tumor cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up. Br J Cancer 69:566-571, 1994. (Pubitemid 24076481)
46. Molino A, Pelosi G, Turazza M, et al: Bone marrow micrometastases in 109 breast cancer patients: correlations with clinical and pathological features and prognosis. Breast Cancer Res Treat 42:23-30, 1997. (Pubitemid 27056725)
47. Mansi JL, Easton D, Berger U, et al: Bone marrow micrometastases in primary breast cancer: Prognostic significance after 6 year' s follow-up. Eur J Cancer 27:1552-1555, 1991.
48. Diel IJ, Kaufmann M, Goerner R, et al: Detection of tumor cells in bone marrow of patients with primary breast cancer: A prognostic factor for distant metastasis. J Clin Oncol10:1534-1539, 1992. (Pubitemid 23057981)